Hyota Takamatsu
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.
Journal: Immunological medicine
Published: June 26, 2026
Strong inhibition of IL-6 signal is clinically and serologically effective in refractory adult-onset Still's disease.
Journal: Rheumatology (Oxford, England)
Published: October 07, 2025
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trial.
Journal: Rheumatology (Oxford, England)
Published: September 09, 2025
Mitochondrial DNA: leakage, recognition and associated human diseases.
Journal: Journal of biochemistry
Published: April 14, 2025
Serum cytokine levels towards precision medicine in Still's disease: a subanalysis of a randomized controlled trial of tocilizumab.
Journal: Rheumatology (Oxford, England)
Published: February 25, 2025
The Ragulator complex and lysosomal calcium release are crucial for cell migration.
Journal: Life science alliance
Published: August 23, 2024
Efficacy of Upadacitinib in refractory Polyarteritis Nodosa: a case report.
Journal: Oxford medical case reports
Published: June 21, 2024
Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 27, 2024
Feasibility and Safety of Utilizing Air Ultrafine Bubble Water for Preoperative Skin Cleaning Before Foot and Ankle Surgery.
Journal: Advances in skin & wound care
Published: March 22, 2024
Gp130-HIF1α axis-induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 02, 2024
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition.
Journal: Biochemical and biophysical research communications
Published: December 16, 2023
A High-Throughput Single-Cell Assay on a Valve-Based Microfluidic Platform Applied to Protein Quantification, Immune Response Monitoring, and Drug Discovery.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 10, 2023
Last Updated: 09/26/2026